Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer

Lancet

Volumn 360, Issue 9345, 2002, Pages 1557-1563

  Harkins, Lualhati ^a   Volk, Andrea L ^b   Samanta, Minu ^a   Mikolaenko, Ivan ^a   Britt, William J ^c   Bland, Kirby I ^d   Cobbs, Charles S ^a,c,d  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; FORMALDEHYDE; MONOCLONAL ANTIBODY; NUCLEIC ACID; PARAFFIN; PROTEIN BCL 2; PROTEIN IE1 72; PROTEIN PP65; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; COLON BIOPSY; COLORECTAL CANCER; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DNA SEQUENCE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; INTESTINE POLYP; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INDUCTION; PROTEIN LOCALIZATION;

EID: 0037121233     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11524-8     Document Type: Article

References (36)

1. Fearon E.R. Molecular biology of gastrointestinal cancers. De Vita V.T. Jr, Hellman S., Rosenberg S.A., Cancer: principles and practice of oncology. 6th edn:2001;1037-1049 Lippincott, Williams, and Wilkins, Philadelphia.
2. Parkin D.M., Pisani P., Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 54:1993;594-606.
3. Birkeland S.A., Storm H.H., Lamm L.U., et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer. 60:1995;183-189.
4. Britt W.J., Alford C.A. Cytomegalovirus. Fields B.N., Knipe D.M., Howley P.M., 3rd edn Fields virology. 2:1996;2493-2523 Lippincott, Williams, and Wilkins, Philadelphia.
5. Doniger J., Sumitra M., Rosenthal L.J. Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate. Clin Microbiol Rev. 12:1999;367-382.
6. Cinatl J. Jr, Cinatl J., Vogel J.U., et al. Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology. 39:1996;259-269.
7. Jarvis M.A., Wang C.E., Meyers H.L., et al. Human cytomegalovirus infection of caco-2 cells occurs at the basolateral membrane and is differentiation state dependent. J Virol. 73:1999;4552-4560.
8. Huang E.S., Roche J.K. Cytomegalovirus DNA and adenocarcinoma of the colon: evidence for latent viral infection. Lancet. 1:1978;957-960.
9. Hashiro G.M., Horikami S., Loh P.C. Cytomegalovirus isolations from cell cultures of human adenocarcinomas of the colon. Intervirology. 12:1979;84-88.
10. Hart H., Neill W.A., Norval M. Lack of association of cytomegalovirus with adenocarcinoma of the colon. Gut. 23:1982;21-30.
11. Ruger R., Fleckenstein B. Cytomegalovirus DNA in colorectal carcinoma tissues. Klin Wochenschr. 63:1985;405-408.
12. Cobbs C.S., Harkins L., Samanta M., et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 62:2002;3347-3350.
13. Williams C., Shattuck-Brandt R.L., DuBois R.N. The role of COX-2 in intestinal cancer. Ann N Y Acad Sci. 889:1999;72-83.
14. Zhu H., Cong J.P., Mamtora G., et al. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc Natl Acad Sci USA. 95:1998;14470-14475.
15. Zhu H., Cong J.P., Yu D., Bresnahan W.A., Shenk T.E. Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci USA. 99:2002;3932-3937.
16. Tsujii M., Kawano S., Tsuji S., et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 93:1998;705-716.
17. Tsujii M., Kawano S., DuBois R.N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA. 94:1997;3336-3340.
18. Cinatl J. Jr, Cinatl J., Vogel J.U., et al. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells. Cancer Res. 58:1998;367-372.
19. Sheng H., Shao J., Morrow J.D., et al. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res. 58:1998;362-366.
20. Merritt A.J., Potten C.S., Watson A.J., et al. Differential expression of bcl-2 in intestinal epithelia: correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Sci. 108:1995;2261-2271.
21. Kuhn J.E., Wendland T., Eggers H.J., et al. Quantitation of human cytomegalovirus genomes in the brain of AIDS patients. J Med Virol. 47:1995;70-82.
22. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 87:1996;159-170.
23. Howley P.M., Ganem D., Kieff E. DNA viruses. De Vita V.T. Jr, Hellman S., Rosenberg S.A., Cancer: principles and practice of oncology. 6th edn:2001;168-173 Lippincott, Williams, and Wilkins, Philadelphia.
24. Sturzl M., Zietz C., Monini P., Ensoli B. Human herpesvirus-8 and Kaposi's sarcoma: relationship with the multistep concept of tumorigenesis. Adv Cancer Res. 81:2001;125-159.
25. Hagemeier C., Walker S.M., Sissons P.J., Sinclair J.H. The 72K IE1 and 80K IE2 proteins of human cytomegalovirus independently trans-activate the c-fos, c-myc and hsp70 promoters via basal promoter elements. J Gen Virol. 73:1992;2385-2393.
26. Johnson R.A., Wang X., Ma X.L., et al. Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J Virol. 75:2001;6022-6032.
27. Johnson R.A., Huong S.M., Huang E.S. Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38. J Virol. 74:2000;1158-1167.
28. Jault F.M., Jault J.M., Ruchti F., et al. Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J Virol. 69:1995;6697-6704.
29. Bresnahan W.A., Albrecht T., Thompson E.A. The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early proteins. J Biol Chem. 273:1998;22075-22082.
30. Yurochko A.D., Kowalik T.F., Huong S.M., Huang E.S. Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J Virol. 69:1995;5391-5400.
31. Muralidhar S., Doniger J., Mendelson E., et al. Human cytomegalovirus mtrII oncoprotein binds to p53 and down-regulates p53-activated transcription. J Virol. 70:1996;8691-8700.
32. Castillo J.P., Yurochko A.D., Kowalik T.F. Role of human cytomegalovirus immediate-early proteins in cell growth control. J Virol. 74:2000;8028-8037.
33. Chen Z., Knutson E., Kurosky A., Albrecht T. Degradation of p21cip1 in cells productively infected with human cytomegalovirus. J Virol. 75:2001;3613-3625.
34. Shen Y., Zhu H., Shenk T. Human cytomegalovirus IE1 and IE2 proteins are mutagenic and mediate "hit and run" oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc Natl Acad Sci USA. 94:1997;3341-3345.
35. Zhu H., Shen Y., Shenk T. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J Virol. 69:1995;7960-7970.
36. Loenen W.A., Bruggeman C.A., Wiertz E.J. Immune evasion by human cytomegalovirus: lessons in immunology and cell biology. Semin Immunol. 13:2001;41-49.